Primary stromal cells isolated from human various histological/pathological prostate have different phenotypes and tumor promotion role

Chinese Medical Journal

Volumn 124, Issue 11, 2011, Pages 1700-1707

  Wang, Xiao Hai ^a   Zhao, Fu Jun ^a   Han, Bang Min ^a   Jiang, Qi ^a   Wang, Yong Chuan ^a   Wu, Jian Hong ^a   Tang, Yue Qing ^b   Zhang, Yue Ping ^c   Xia, Shu Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Cluster analysis; Peripheral zone; Prostate cancer; Stromal cells

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PHENOTYPE; PROSTATE CANCER; PROSTATE CANCER ASSOCIATED PRIMARY STROMAL CELL; PROSTATIC PERIPHERAL ZONAL PRIMARY STROMAL CELL; PROSTATIC TRANSITIONAL ZONAL PRIMARY STROMAL CELL; STROMA CELL; TUMOR PROMOTION;

ADULT; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CLUSTER ANALYSIS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE; PROSTATIC NEOPLASMS; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 79957894985     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.11.018     Document Type: Article

References (32)

1. Cunha GR, Hayward SW, Wang YZ. Role of stroma in carcinogenesis of the prostate. Differentiation 2002; 70: 473-485.
2. Lee KL, Peehl DM. Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 2004; 172: 1784-1791.
3. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005; 173: 10-20.
4. Niu YN, Xia SJ. Stroma, epithelium crosstalk in prostate cancer. Asian J Androl 2009; 11: 28-35.
5. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-447.
6. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15: 97-101.
7. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-337.
8. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008; 18: 27-34.
9. West RB, van de Rijn M. Experimental approaches to the study of cancer-stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis. Lab Invest 2007; 87: 967-970.
10. San Francisco IF, DeWolf WC, Peehl DM, Olumi AF. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int J Cancer 2004; 112: 213-218.
11. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 2005; 146: 13-18.
12. Pavelić J, Zeljko Z, Bosnar MH. Molecular genetic aspects of prostate transition zone lesions. Urology 2003; 62: 607-613.
13. Zhao FJ, Han BM, Yu SQ, Xia SJ. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate. Asian J Androl 2009; 11: 176-182.
14. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, et al. Gene promoter methylation in prostate tumor-associated stromal cells. J Natl Cancer Inst 2006; 98: 255-261.
15. Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, et al. Identification of a unique epigenetic sub-microenvironment in prostate cancer. J Pathol 2007; 211: 410-419.
16. Jiang J, Wang LF, Fang YH, Jin FS, Jin WS. Proliferative response of human prostate cancer cell to hormone inhibited by androgen receptor antisense RNA. Chin Med J 2004; 117: 684-688.
17. Yu SQ, Han BM, Shao Y, Wu JT, Zhao FJ, Liu HT, et al. Androgen receptor functioned as a suppressor in the prostate cancer cell line PC3 in vitro and in vivo. Chin Med J 2009; 122: 2779-2783.
18. Peehl DM. Primary cell cultures as models of prostate cancer development. Endocrine Relat Cancer 2005; 12: 19-47.
19. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8: 2912-2923.
20. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-5011.
21. Chung LW, Chang SM, Bell C, Zhau HE, Ro JY, von Eschenbach AC. Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int J Cancer 1989; 43: 1179-1187.
22. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001; 61: 8135-8142.
23. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL. Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF): FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993; 13: 4513-4522.
24. Takeshita S, Kikuno R, Tezuka K, Amann E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 1993; 294: 271-278.
25. Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999; 14: 1239-1249.
26. Kim JE, Kim SJ, Lee BH, Park RW, Kim KS, Kim IS. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3. J Biol Chem 2000; 275: 30907-30915.
27. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002; 62: 5358-5364.
28. Kudo Y, Siriwardena BS, Hatano H, Ogawa I, Takata T. Periostin: novel diagnostic and therapeutic target for cancer. Histol Histopathol 2007; 22: 1167-1174.
29. Furusato B, Tsunoda T, Shaheduzzaman S, Nau ME, Vahey M, Petrovics G, et al. Osteoblast-specific factor 2 expression in prostate cancer-associated stroma: identification through microarray technology. Urology 2010; 75: 768-772.
30. Tsunoda T, Furusato B, Takashima Y, Ravulapalli S, Dobi A, Srivastava S, et al. The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. Prostate 2009; 69: 1398-1403.
31. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP. Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate 2010; 70: 473-481.
32. Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, et al. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. Clin Cancer Res 2009; 15: 2979-2987.